Comments*

 
  • Surgery and Cognition

    Delirium, Cognitive Decline, and Opportunities to Protect the Brain

    Surgery and Cognition

    Delirium, Cognitive Decline, and Opportunities to Protect the Brain

    Featuring: Sharon Inouye (Harvard Medical School)Presented by The Alzheimer's Drug Discovery Foundation and the Brain Dysfunction Discussion Group
    Reported by Alla Katsnelson | Posted November 21, 2016

    Overview

    Tens of millions of surgeries are conducted in the U.S. every year on people over the age of 65. With surgical procedures becoming increasingly safer and capable of promoting continued mobility and functionality into old age, the frequency of surgeries in the elderly will probably continue to rise. And yet, these procedures can have a dark side: for a significant percentage of elderly patients, anesthesia and surgery can lead to postoperative delirium and possibly long-term cognitive decline.

    The risk of experiencing these postoperative complications depends on the type of surgery and the condition of any given patient. Despite the high incidence of these conditions, they are often overlooked in the clinic, and their underlying mechanism and long-term effects are poorly understood. On June 21, 2016, the Alzheimer's Drug Discovery Foundation partnered with the Brain Dysfunction Discussion Group at the Academy to convene Surgery and Cognition: Delirium, Cognitive Decline, and Opportunities to Protect the Brain. At this meeting, leading scientists and physicians discussed the challenges and opportunities to creating biomarkers and therapeutics for patients who are vulnerable to delirium, cognitive decline, and dementia following surgery.

    Use the tabs above to find a meeting report and multimedia from this event.

     

    Presentations available from:
    Michael S. Avidan, MBBCh, FCASA (Washington University School of Medicine)
    Miles Berger, MD, PhD (Duke University Medical Center)
    Marek Brzezinski, MD, PhD (University of California, San Francisco)
    Sharon Inouye, MD, MPH (Harvard Medical School)
    Edward R. Marcantonio, MD, SM (Beth Israel Deaconess Medical Center)
    Mervyn Maze, MB, ChB (University of California, San Francisco)
    Joshua Mincer, MD, PhD (Icahn School of Medicine at Mount Sinai)
    Claudia Spies (Charité-University Medicine Berlin)
    Zhongcong Xie, MD, PhD (Massachusetts General Hospital & Harvard Medical School)


    Presented by

    • Alzheimer's Drug Discovery Foundation
    • The New York Academy of Sciences

     

    The Brain Dysfunction Discussion Group is proudly supported by


    • Acorda Therapeutics

    How to cite this eBriefing

     

    The New York Academy of Sciences. Surgery and Cognition: Delirium, Cognitive Decline, and Opportunities to Protect the Brain . Academy eBriefings. 2016. Available at: www.nyas.org/POCD-eB

    EmailPrint